Life & health · Specialized
A gadolinium chelate changes image contrast
Some MRI examinations use a gadolinium-containing molecular compound to alter the signal behavior that distinguishes structures within the body.
THE MATERIAL THAT DOES THE WORK
Chemical form
The administered material is a formulated chelated compound, rather than gadolinium metal. For example, gadobutrol is a macrocyclic gadolinium complex supplied as a sterile aqueous solution.
Gadavist (gadobutrol) prescribing information, revised January 2024
- 01
Create the molecular agent
Gadolinium is incorporated into a specified chelated complex, giving the product a defined molecular identity.
- 02
Formulate the product
The complex is supplied in a sterile solution with controlled composition for administration during selected examinations.
- 03
Acquire the image
The MRI system measures radiofrequency signals; the agent changes contrast within the resulting digital images.
Gadavist (gadobutrol) prescribing information, revised January 2024MRI (Magnetic Resonance Imaging)
Why it works
A paramagnetic contrast agent changes relaxation behavior in a magnetic field. Gadobutrol shortens relaxation times; the resulting image effect depends on concentration, magnetic-field strength, and the imaging sequence.
Gadavist (gadobutrol) prescribing information, revised January 2024
How it is made & used
The gadolinium complex is formulated with specified supporting ingredients and water for injection. The final product has controlled chemical and physical properties and is supplied for professional clinical use.
Gadavist (gadobutrol) prescribing information, revised January 2024
Inside the application
MRI creates images using strong magnetic fields and radiofrequency signals, with much of the signal originating from protons in water and fat. A contrast agent changes how parts of that signal appear. It is one component of an imaging examination, while the scanner and its acquisition method generate the underlying image.
Limits & alternatives
Contrast use is a clinical decision. Risks include hypersensitivity reactions and nephrogenic systemic fibrosis in susceptible patients with impaired elimination. Gadolinium can remain in tissues after administration; retention differs among compounds.
Gadavist (gadobutrol) prescribing information, revised January 2024
Part of a larger system
Hydrogen supplies much of the measured MRI signal, while the gadolinium-containing compound modifies its behavior. The example links two elements with different roles: the material being observed and an agent that helps distinguish parts of the image.
Sources & further reading
- Gadavist (gadobutrol) prescribing information, revised January 2024 ↗Bayer HealthCare Pharmaceuticals / U.S. Food and Drug AdministrationTechnical documentation · Source checked Where to look: First label in the PDF: §§11–12.2 on viewer pp. 10–11; §§5.2–5.4 on viewer pp. 5–6.The 68-page file contains repeated labeling sections for presentations. This locator points to the first copy of the January 2024 label, not a claim that it is the latest approval.
- MRI (Magnetic Resonance Imaging) ↗U.S. Food and Drug AdministrationReference explanation · Source checked
Sources and further reading. What the review labels mean